Zobrazeno 1 - 10
of 21
pro vyhledávání: '"J. J. Pérez Ruixo"'
Autor:
I. Quintana Vargas, G. Martínez Romero, A. López Sáez, J. J. Pérez Ruixo, N. V. Jiménez Torres
Publikováno v:
Nutrición Hospitalaria, Vol 18, Iss 4, Pp 215-221 (2003)
Objetivo: Valorar la utilidad del control ponderal como método rutinario de garantía de calidad en la preparación de las unidades nutrientes parenterales (UNP). Material y métodos: En acuerdo con su frecuencia de utilización se seleccionaron dos
Externí odkaz:
https://doaj.org/article/e0e40c582c7849c283aef6de7203d3c6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 3, Pp 154-161 (2014)
Objective: To evaluate the in vitro physicochemical stability of oxaliplatin anddoxorubicin when the in vivo hyperthermic intraperitoneal conditions arereproduced. Methods: Three solutions were prepared, A (oxaliplatin 200 mg/L), B(doxorubicin 15 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::e90905924c1df18c10f8edc9a14ab9bf
http://www.aulamedica.es/fh/pdf/1170.pdf
http://www.aulamedica.es/fh/pdf/1170.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B, Valenzuela Jiménez, M, González Sales, V, Escudero Ortiz, E, Martínez Navarro, C, Pérez Ruixo, J, Rebollo Liceaga, R, González Manzano, J J, Pérez Ruixo
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 37(2)
To evaluate the influence of genetic polymorphism in UGT1A1, UGT1A7 and UGT1A9 on the population pharmacokinetics of irinotecan and its metabolites, SN-38 and SN-38G.Plasma concentrations of irinotecan, SN-38 and SN- 38G from 72 patients were pooled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44f52fd997da271d409d82bd47ecbd36
https://pubmed.ncbi.nlm.nih.gov/23789755
https://pubmed.ncbi.nlm.nih.gov/23789755
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 36(5)
To develop and internally validate a population pharmacokinetics model for cisplatin and assess its prediction capacity for personalising doses in cancer patients.Cisplatin plasma concentrations in forty-six cancer patients were used to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d311aae49a29b92f3d13742b21e4756
https://pubmed.ncbi.nlm.nih.gov/22402361
https://pubmed.ncbi.nlm.nih.gov/22402361
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 36(4)
To develop and internally validate a population pharmacokinetic model for gemcitabine and its metabolite 2',2'-difluorodeoxyuridine (dFdU); and to evaluate its predictive perfomance for personalizing the dosage used in cancer patients.Gemcitabine and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32cb3185ed56d0c8dedc399f02cc2484
https://pubmed.ncbi.nlm.nih.gov/22078546
https://pubmed.ncbi.nlm.nih.gov/22078546
[Populational pharmacokinetics of doxorubicin applied to personalised its dosing in cancer patients]
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 36(4)
To develop and internally validate a population pharmacokinetic model for doxorubicin and to evaluate its predictive performance for dose individualization in cancer patients.Doxorubicin plasma concentrations were determined in thirty-three cancer pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5cc70c0aa68cd07ee46989cb88358eb6
https://pubmed.ncbi.nlm.nih.gov/22129650
https://pubmed.ncbi.nlm.nih.gov/22129650
Autor:
J J, Pérez-Ruixo, B, Valenzuela
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 29(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::160e19b47981de16215a1c1f145dba22
https://pubmed.ncbi.nlm.nih.gov/16013940
https://pubmed.ncbi.nlm.nih.gov/16013940
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 24(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f676668bb7e95880ebb05126886dd3c
https://pubmed.ncbi.nlm.nih.gov/15648900
https://pubmed.ncbi.nlm.nih.gov/15648900